Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$22.90

-0.5 (-2.14%)

, BAX

Baxter

$69.18

0.77 (1.13%)

07:47
01/08/18
01/08
07:47
01/08/18
07:47

Mallinckrodt to sell RECOTHROM, PREVELEAK to Baxter for about $185M

MNK

Mallinckrodt

$22.90

-0.5 (-2.14%)

BAX

Baxter

$69.18

0.77 (1.13%)

  • 08

    Jan

  • 26

    Feb

  • 27

    Feb

MNK Mallinckrodt
$22.90

-0.5 (-2.14%)

12/29/17
CANT
12/29/17
NO CHANGE
Target $42
CANT
Overweight
Cantor doesn't see competing bid to Mallinckrodt's for Sucampo
Citing the merger documents and his own diligence, Cantor Fitzgerald analyst Louise Chen finds it unlikely that another company would step in for Sucampo Pharmaceuticals (SCMP) as a counter to Mallinckrodt's (BID). Further, Mallinckrodt discounted the value ascribed to Sucampo's pipeline assets, but having a product like Amitiza allows it to limit the purchase price risk, Chen told investors yesterday in a research note. She does not think the January 28 FDA action date for Sucampo's Amitiza pediatric supplemental drug application should be a meaningful stock catalyst. The analyst keeps an Overweight rating on Mallinckrodt with a $42 price target.
01/02/18
LEER
01/02/18
INITIATION
Target $26
LEER
Market Perform
Mallinckrodt initiated with a Market Perform at Leerink
Leerink analyst Ami Fadia initiated Mallinckrodt with a Market Perform and $26 price target.
01/03/18
STFL
01/03/18
NO CHANGE
STFL
Mallinckrodt added to Select List, Jazz Pharmaceuticals removed at Stifel
01/05/18
UBSW
01/05/18
DOWNGRADE
Target $18
UBSW
Neutral
Sucampo downgraded to Neutral from Buy at UBS
UBS analyst Marc Goodman downgraded Sucampo Pharmaceuticals (SCMP) to Neutral to reflect the takeover by Mallinckrodt (MNK). The analyst believes the deal is likely to close without significant issues and upped his price target for the shares to $18 from $15.
BAX Baxter
$69.18

0.77 (1.13%)

01/02/18
BOFA
01/02/18
UPGRADE
Target $73
BOFA
Buy
Baxter upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Baxter to Buy from Neutral and increased its price target to $73 from $64. Analyst Bob Hopkins expects Baxter to put its $7B balance sheet liquidity to work through M&A and buybacks, which should set the stage for improving revenue growth in 2019-20.
01/02/18
01/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. L Brands (LB) upgraded to Outperform from Neutral at Baird with analyst Mark Altschwagern saying he believes the company is on track to meet or exceed December comparable sales and fourth quarter expectations. 2. Lennar (LEN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Stephen East citing his post-tax reform earnings per share estimate but without the CalAtlantic (CAA) acquisition included. 3. Disney (DIS), Netflix (NFLX), AMC Networks (AMCX), and Discovery (DISCA) were upgraded to Outperform from Neutral at Macquarie. 4. Abbott (ABT) was upgraded to Overweight from Equal Weight at Morgan Stanley and to Overweight from Neutral at JPMorgan. 5. Baxter (BAX) was upgraded to Buy from Neutral at BofA/Merrill and to Overweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/18
RAJA
01/03/18
UPGRADE
Target $73
RAJA
Outperform
Baxter upgraded to Outperform, view as a core holding at Raymond James
Raymond James analyst Lawrence Keusch upgraded Baxter to Outperform from Market Perform and established a $73 price target saying he views it as a core holding. Keusch has high confidence in management execution, an emerging new product portfolio, and balance sheet optionality. He sees organic cc revenue growth in the 4% range driven by geographic expansion after recent underperformance in Europe, as well as continued growth in Asia. Further, after a period of underinvestment, the R&D pipeline as been revitalized and should begin to accelerate growth in 2019 and beyond. Finally, the analyst said Baxter has considerable balance sheet flexibility with $7-$8B available for bolt-on acquisitions.
01/03/18
EVER
01/03/18
INITIATION
Target $71
EVER
Outperform
Baxter initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Baxter with an Outperform rating and $71 price target. The analyst thinks Baxter should be able to meet or beat 2018 Street expectations and its balance sheet strength gives it over $10B in capacity for M&A, he tells investors.

TODAY'S FREE FLY STORIES

GME

GameStop

$12.60

0.3 (2.44%)

12:50
11/21/18
11/21
12:50
11/21/18
12:50
Hot Stocks
GameStop says board still reviewing strategic, financial alternatives »

"This transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

GME

GameStop

$12.60

0.3 (2.44%)

12:49
11/21/18
11/21
12:49
11/21/18
12:49
Hot Stocks
GameStop to sell Spring Mobile unit to Prime Communications for $700M »

GameStop (GME) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

12:45
11/21/18
11/21
12:45
11/21/18
12:45
General news
Breaking General news story  »

Week of 11/21…

GME

GameStop

$12.60

0.3 (2.44%)

12:44
11/21/18
11/21
12:44
11/21/18
12:44
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OMC

Omnicom

$76.77

1.06 (1.40%)

, WPP

WPP

$54.99

1.4 (2.61%)

12:42
11/21/18
11/21
12:42
11/21/18
12:42
Hot Stocks
Omnicom rises after winning $4B U.S. Army ad account »

Shares of Omnicom (OMC)…

OMC

Omnicom

$76.77

1.06 (1.40%)

WPP

WPP

$54.99

1.4 (2.61%)

F

Ford

$9.16

0.1 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

RHT

Red Hat

$173.28

-0.22 (-0.13%)

, IBM

IBM

$118.90

1.73 (1.48%)

12:41
11/21/18
11/21
12:41
11/21/18
12:41
Periodicals
EC review of Red Hat-IBM deal to 'zoom in' on middleware, Dealreporter says »

The European Commission…

RHT

Red Hat

$173.28

-0.22 (-0.13%)

IBM

IBM

$118.90

1.73 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

AAL

American Airlines

$36.91

1.31 (3.68%)

12:36
11/21/18
11/21
12:36
11/21/18
12:36
Periodicals
American Airlines glitch briefly hampers travelers, USA Today reports »

A computer glitch in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$48.54

0.22 (0.46%)

, FOXA

21st Century Fox

$48.84

0.25 (0.51%)

12:25
11/21/18
11/21
12:25
11/21/18
12:25
OnTheFly
Box Office Battle: 'Wreck-It Ralph' seen knocking out 'Beasts,' 'Creed' »

DISNEY EXPECTED TO WIN…

FOX

21st Century Fox

$48.54

0.22 (0.46%)

FOXA

21st Century Fox

$48.84

0.25 (0.51%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$37.34

0.59 (1.61%)

T

AT&T

$29.95

0.54 (1.84%)

DIS

Disney

$113.45

1.67 (1.49%)

VIA

Viacom

$35.28

1.06 (3.10%)

VIAB

Viacom

$31.82

1 (3.24%)

SNE

Sony

$50.75

1.21 (2.44%)

LGF.A

Lionsgate

$19.08

0.77 (4.21%)

LGF.B

Lionsgate

$17.64

0.78 (4.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 29

    Nov

  • 03

    Dec

  • 04

    Dec

AG

First Majestic

$5.52

0.28 (5.34%)

12:25
11/21/18
11/21
12:25
11/21/18
12:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/21/18
11/21
12:17
11/21/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/21/18
11/21
12:16
11/21/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.79

0.69 (0.39%)

, DE

Deere

$143.72

5.23 (3.78%)

12:15
11/21/18
11/21
12:15
11/21/18
12:15
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in positive…

AAPL

Apple

$177.79

0.69 (0.39%)

DE

Deere

$143.72

5.23 (3.78%)

GPS

Gap

$25.58

0.93 (3.77%)

FB

Facebook

$136.30

3.83 (2.89%)

TNDM

TNDM

BZUN

Baozun

$33.26

3.19 (10.61%)

FL

Foot Locker

$52.48

6.38 (13.84%)

JNJ

Johnson & Johnson

$142.00

-4.44 (-3.03%)

CAL

Caleres

$28.43

-2.5 (-8.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 12

    Dec

  • 03

    Mar

NKTR

Nektar

$37.50

-0.7 (-1.83%)

12:05
11/21/18
11/21
12:05
11/21/18
12:05
Options
Nektar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

HD

Home Depot

$170.35

1.18 (0.70%)

12:03
11/21/18
11/21
12:03
11/21/18
12:03
Hot Stocks
Home Depot director Mark Vadon purchases over $2M worth of company stock »

Home Depot director Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$36.77

0.29 (0.79%)

, AQST

Aquestive Therapeutics

$9.71

-3.465 (-26.31%)

12:02
11/21/18
11/21
12:02
11/21/18
12:02
Recommendations
Dr. Reddy's, Aquestive Therapeutics analyst commentary  »

BMO says Aquestive loss…

RDY

Dr. Reddy's

$36.77

0.29 (0.79%)

AQST

Aquestive Therapeutics

$9.71

-3.465 (-26.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AET

Aetna

$205.78

1.635 (0.80%)

, CVS

CVS Health

$75.77

0.25 (0.33%)

12:02
11/21/18
11/21
12:02
11/21/18
12:02
Hot Stocks
NJ state clears CVS-Aetna merger »

According to a filing,…

AET

Aetna

$205.78

1.635 (0.80%)

CVS

CVS Health

$75.77

0.25 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

12:01
11/21/18
11/21
12:01
11/21/18
12:01
General news
EIA natural gas storage change for week ending November 16 »

Gas inventories 134 Bcf…

GS

Goldman Sachs

$193.29

1.95 (1.02%)

11:55
11/21/18
11/21
11:55
11/21/18
11:55
Periodicals
Abu Dhabi fund sues Goldman Sachs over 1MDB scandal, FT says »

Abu Dhabi's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNHBF

ICC International Cannabis

$0.00

(0.00%)

, CGC

Canopy Growth

$34.08

2.17 (6.80%)

11:51
11/21/18
11/21
11:51
11/21/18
11:51
OnTheFly
Rising High: International Cannabis agrees to acquire Green Gene »

Welcome to "Rising High,"…

KNHBF

ICC International Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$34.08

2.17 (6.80%)

MMNFF

MedMen

$0.00

(0.00%)

ACB

Aurora Cannabis

$6.27

0.23 (3.81%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$8.57

0.38 (4.64%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$0.00

(0.00%)

TLRY

Tilray

$107.50

3.56 (3.43%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CRM

Salesforce

$124.33

3.61 (2.99%)

11:50
11/21/18
11/21
11:50
11/21/18
11:50
Options
Put spread in Salesforce as shares bounce 3% »

Put spread in Salesforce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Treasury's $11 B 10-year TIPS reopening was ok »

Treasury's $11 B…

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Atlanta Fed's Q4 GDPNow estimate was unchanged at 2.5% »

Atlanta Fed's Q4…

11:45
11/21/18
11/21
11:45
11/21/18
11:45
General news
Breaking General news story  »

Week of 11/16 EIA Natural…

AQST

Aquestive Therapeutics

$9.60

-3.57 (-27.11%)

, RDY

Dr. Reddy's

$36.89

0.41 (1.12%)

11:44
11/21/18
11/21
11:44
11/21/18
11:44
Recommendations
Aquestive Therapeutics, Dr. Reddy's analyst commentary  »

Aquestive selloff on…

AQST

Aquestive Therapeutics

$9.60

-3.57 (-27.11%)

RDY

Dr. Reddy's

$36.89

0.41 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

HIG

Hartford Financial

$44.70

0.6 (1.36%)

11:40
11/21/18
11/21
11:40
11/21/18
11:40
Options
Higher option volume in Hartford fueled by call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.